
H.C. Wainwright reiterated its Buy rating and $116 price target for Transcat Inc. (TRNS), citing favorable business momentum despite the stock's recent flat performance. The firm projects 8.6% revenue growth for fiscal year 2026, driven by high single-digit organic growth, recent acquisitions, and sustained demand across highly regulated core segments like life sciences and defense. H.C. Wainwright anticipates gross margin improvements from automation and recommends accumulating shares, highlighting the company's revenue visibility and long-term growth potential.
H.C. Wainwright has reaffirmed its Buy rating and an $116 price target for Transcat Inc. (TRNS), signaling strong confidence in the company's fundamental trajectory despite recent stock performance lagging the Russell 2000 index slightly (2.4% gain for TRNS vs. 2.7% for the index since May 19). The positive outlook is anchored by sustained high single-digit organic growth in its core service segment, supplemented by revenue from strategic acquisitions such as Martin Calibration. The firm projects an 8.6% revenue increase for fiscal year 2026, viewing Transcat's active M&A strategy as a source of potential upside. Furthermore, margin expansion is a key component of the thesis, with expectations for gross margins to improve towards 35.0% driven by the implementation of automation in its calibration services. Transcat's strategic focus on highly regulated and non-discretionary end markets, including life sciences and defense, provides significant revenue visibility and a defensive moat against macroeconomic volatility.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment